121 related articles for article (PubMed ID: 32602016)
41. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning.
Gelpi RJ; Morales C; Cohen MV; Downey JM
Basic Res Cardiol; 2002 Jan; 97(1):40-6. PubMed ID: 11998976
[TBL] [Abstract][Full Text] [Related]
42. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
43. Metabolic and functional effects of carbachol and ischaemic preconditioning in rat isolated heart.
Pisarenko OI; Shulzhenko VS; Studneva IM
Clin Exp Pharmacol Physiol; 1999 Jan; 26(1):26-31. PubMed ID: 10027066
[TBL] [Abstract][Full Text] [Related]
44. Calcium regulation of glycolysis, glucose oxidation, and fatty acid oxidation in the aerobic and ischemic heart.
Schönekess BO; Brindley PG; Lopaschuk GD
Can J Physiol Pharmacol; 1995 Nov; 73(11):1632-40. PubMed ID: 8789418
[TBL] [Abstract][Full Text] [Related]
45. Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart.
Starkopf J; Bugge E; Ytrehus K
Cardiovasc Res; 1997 Jan; 33(1):63-70. PubMed ID: 9059529
[TBL] [Abstract][Full Text] [Related]
46. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
Bugge E; Ytrehus K
Cardiovasc Res; 1995 Mar; 29(3):401-6. PubMed ID: 7781014
[TBL] [Abstract][Full Text] [Related]
47. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning.
Jenkins DP; Pugsley WB; Yellon DM
J Mol Cell Cardiol; 1995 Aug; 27(8):1623-32. PubMed ID: 8523425
[TBL] [Abstract][Full Text] [Related]
48. Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium.
Sumeray MS; Yellon DM
Basic Res Cardiol; 1998 Oct; 93(5):384-90. PubMed ID: 9833150
[TBL] [Abstract][Full Text] [Related]
49. Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium.
Tosaki A; Pali T; Droy-Lefaix MT
Diabetologia; 1996 Nov; 39(11):1255-62. PubMed ID: 8932989
[TBL] [Abstract][Full Text] [Related]
50. Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation.
Fraser H; Lopaschuk GD; Clanachan AS
Br J Pharmacol; 1999 Sep; 128(1):197-205. PubMed ID: 10498852
[TBL] [Abstract][Full Text] [Related]
51. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart.
Harrison GJ; Willis RJ; Headrick JP
Cardiovasc Res; 1998 Oct; 40(1):74-87. PubMed ID: 9876319
[TBL] [Abstract][Full Text] [Related]
52. Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo.
McAllister A; Allison SP; Randle PJ
Biochem J; 1973 Aug; 134(4):1067-81. PubMed ID: 4762752
[TBL] [Abstract][Full Text] [Related]
53. The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins.
Lawson CS; Coltart DJ; Hearse DJ
Cardiovasc Res; 1993 Apr; 27(4):681-7. PubMed ID: 8324805
[TBL] [Abstract][Full Text] [Related]
54. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts.
McCormack JG; Barr RL; Wolff AA; Lopaschuk GD
Circulation; 1996 Jan; 93(1):135-42. PubMed ID: 8616920
[TBL] [Abstract][Full Text] [Related]
55. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.
Saddik M; Lopaschuk GD
J Biol Chem; 1991 May; 266(13):8162-70. PubMed ID: 1902472
[TBL] [Abstract][Full Text] [Related]
56. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart.
Lasley RD; Anderson GM; Mentzer RM
Cardiovasc Res; 1993 Apr; 27(4):565-70. PubMed ID: 8324787
[TBL] [Abstract][Full Text] [Related]
57. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
58. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
[TBL] [Abstract][Full Text] [Related]
59. Myocardial triggers involved in activation of remote ischaemic preconditioning.
Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
[TBL] [Abstract][Full Text] [Related]
60. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines.
Lawson CS; Hearse DJ
Cardiovasc Res; 1996 Apr; 31(4):655-62. PubMed ID: 8689659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
